We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
Prime Medicine
PRME
$671M
| $78.6K | ﹤0.01% |
21,295
-6,951
| -25% | -$23.1K |
|
4077
Fulcrum Therapeutics
FULC
$294M
| $78.2K | ﹤0.01% |
21,373
-42,716
| -67% | -$260K |
|
|
GLDG
4078
GoldMining Inc
GLDG
$232M
| $78.2K | ﹤0.01% |
86,199
-6,509
| -7% | -$7.28K |
|
4079
Riverview Bancorp
RVSB
$106M
| $76.8K | ﹤0.01% |
14,138
+119
| +0.8% | +$659 |
|
4080
InspireMD
NSPR
$40M
| $76.3K | ﹤0.01% |
108,964
+89,250
| +453% | +$94.6K |
|
4081
Conduent
CNDT
$302M
| $76.2K | ﹤0.01% |
52,201
+22,276
| +74% | +$34.6K |
|
|
ARBK
4082
Argo Blockchain
ARBK
$42.6M
| $76K | ﹤0.01% |
+20,005
| New | +$69.9K |
|
4083
Richtech Robotics
RR
$394M
| $75.9K | ﹤0.01% |
35,979
+7,361
| +26% | +$17.9K |
|
4084
Oportun Financial
OPRT
$362M
| $73.9K | ﹤0.01% |
+12,936
| New | +$69.3K |
|
|
INFQ
4085
Infleqtion Inc
INFQ
$2.9B
| $70.4K | ﹤0.01% |
+5,284
| New | +$72.7K |
|
|
HURA
4086
TuHURA Biosciences
HURA
$136M
| $66.4K | ﹤0.01% |
28,397
-2,497
| -8% | -$5.82K |
|
4087
Standard BioTools
LAB
$269M
| $66.1K | ﹤0.01% |
80,331
+61,863
| +335% | +$58.5K |
|
4088
Televisa
TV
$1.39B
| $65.2K | ﹤0.01% |
24,077
-30,279
| -56% | -$86.8K |
|
4089
X4 Pharmaceuticals
XFOR
$401M
| $64.8K | ﹤0.01% |
13,872
+53
| +0.4% | +$217 |
|
4090
American Resources Corp
AREC
$260M
| $64K | ﹤0.01% |
29,768
+3,077
| +12% | +$6.88K |
|
4091
CALL
Uber
UBER
$155B
| $63.3K | ﹤0.01% |
+5,000
| New | +$367K |
|
|
USAS
4092
Americas Gold and Silver
USAS
$1.81B
| $62.9K | ﹤0.01% |
+13,332
| New | +$76.9K |
|
4093
Cardiff Oncology
CRDF
$84.8M
| $62.5K | ﹤0.01% |
48,097
+4,487
| +10% | +$7.12K |
|
4094
Nkarta
NKTX
$209M
| $62.2K | ﹤0.01% |
+21,990
| New | +$61.9K |
|
4095
VTEX
VTEX
$597M
| $61.5K | ﹤0.01% |
15,384
+4,739
| +45% | +$18.1K |
|
|
OPLN
4096
CALL
Openlane
OPLN
$4.33B
| $61K | ﹤0.01% |
+5,300
| New | +$185K |
|
4097
CALL
iShares Silver Trust
SLV
$32.2B
| $60.3K | ﹤0.01% |
+18,400
| New | +$1.22M |
|
4098
Rimini Street
RMNI
$468M
| $59.9K | ﹤0.01% |
+14,070
| New | +$53.3K |
|
4099
CALL
Intel
INTC
$506B
| $59.7K | ﹤0.01% |
+900
| New | +$91K |
|
4100
Microvision
MVIS
$50.5M
| $59.7K | ﹤0.01% |
12,168
+405
| +3% | +$3.34K |
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.